.

    Draft Guidance from the FDA Suggests Important Changes to Drug Development
    source: shutterstock.com

    Draft Guidance from the FDA Suggests Important Changes to Drug Development

    On February 1, 2023, FDA issued a Draft Guidance Document, called “Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products” (Docket ID: FDA-2022-D-2983).  The Draft Guidance considers…

    Continue Reading Draft Guidance from the FDA Suggests Important Changes to Drug Development
    Upcoming IDF Session on CGD!
    https://pixabay.com/en/africa-zebra-black-and-white-safari-1203936/

    Upcoming IDF Session on CGD!

    A special session on CGD will be presented at the 2017 IDF National conference. CGD is a primary immunodeficieny disease and is characterized by skin infections, both fungal and bacterial,…

    Continue Reading Upcoming IDF Session on CGD!
    2017 International Vasculitis Symposium
    https://pixabay.com/en/foliage-macro-colorful-leaf-1839755/

    2017 International Vasculitis Symposium

    Do you have VASCULITIS? Associated with: Behcet’s Disease, Churg Strauss Syndrome, Cryoglobulinemia, Giant Cell Arteritis (Temporal Arteritis), Granulomatosis with Polyangiitis (formerly Wegener’s Granulomatosis), Hpersensitivity Vasculitis (Leukocytoclastic), IgA Vasculitis (Henoch-Schönlein Purpura), Kawasaki…

    Continue Reading 2017 International Vasculitis Symposium
    2017 Muscular Dystrophy Association Scientific Conference: A Beacon of Light!
    mohamed_hassan / Pixabay

    2017 Muscular Dystrophy Association Scientific Conference: A Beacon of Light!

    2017 Muscular Dystrophy Association Scientific Conference was a beacon of light! Researchers from academic medical centers,  pharmaceutical companies, children’s’ medical centers, biotech, engineering,  and veterinary medicine came together to share…

    Continue Reading 2017 Muscular Dystrophy Association Scientific Conference: A Beacon of Light!